Physician profile
Patrick M Obeirne
NPI 1215969753
$1,432.36
in general payments reported to CMS, 2019-2025
12 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $25.79 · 2021: $16.80 · 2022: $401 · 2023: $242 · 2024: $189 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $475.47 | 2020-2024 | Aveir, Jot Dx |
| Medtronic Vascular, INC. | $245.07 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $142.76 | 2021-2022 | |
| Pfizer INC. | $133.93 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $133.66 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2022 | |
| Baxter Healthcare | $77.61 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Medicomp INC | $26.79 | 2025 | Telepatch Cardiac Monitor |
| Amgen INC. | $21.97 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $19.97 | 2025 | Eliquis |
| Amarin Pharma, INC. | $18.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Obeirne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.